NIAID Discovery Leads to Novel Probiotic for Eczema Scientists Identified Beneficial Bacteria that Relieve Eczema Symptoms in Adults and Children

https://www.niaid.nih.gov/news-events/niaid-discovery-leads-novel-probiotic-eczema?utm_campaign=+61154383&utm_content=&utm_medium=email&utm_source=govdelivery&utm_term= NIAID scientists discovered that bacteria present on healthy skin called Roseomonas mucosa can safely relieve eczema symptoms in adults and children. That research has led to the availability of a novel over-the-counter topical eczema probiotic. Eczema—also known as atopic dermatitis—is a chronic inflammatory skin condition that affects approximately 20% of children and 10% of adults worldwide.